Leptin: A biomarker for sleep disorders?

Sleep Medicine Reviews

Volumn 18, Issue 3, 2014, Pages 283-290

  Pan, Weihong ^a   Kastin, Abba J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

AHI; BBB; BMI; Circadian rhythm; CNS; Continuous positive airway pressure; CPAP; EDS; Leptin; Obstructive sleep apnea; OSA; PAP; REM; Sleep duration; Sleep fragmentation

Indexed keywords

BIOLOGICAL MARKER; LEPTIN;

HUMAN; HYPERLEPTINEMIA; INCREASED APPETITE; NONHUMAN; OBESITY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SENSITIVITY AND SPECIFICITY; SLEEP DISORDER; SLEEP DISORDERED BREATHING; SLEEP FRAGMENTATION; SLEEP PARAMETERS; SLEEP TIME; APPETITE; BLOOD; DIAGNOSIS; PHYSIOLOGY; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION; SLEEP DISORDERS; THERAPY; TREATMENT OUTCOME;

APPETITE; BIOLOGICAL MARKERS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; LEPTIN; OBESITY; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 84921850827     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2013.07.003     Document Type: Review

References (85)

1. Banks W.A., Kastin A.J., Huang W., Jaspan J.B., Maness L.M. Leptin enters the brain by a saturable system independent of insulin. Peptides 1996, 17:305-311.
2. Banks W.A. The many lives of leptin. Peptides 2004, 25:331-338.
3. Banks W.A., Clever C.M., Farrell C.L. Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice. Am J Physiol 2000, 278:E1158-E1165.
4. Kastin A.J., Akerstrom V. Fasting, but not adrenalectomy, reduces transport of leptin into the brain. Peptides 2000, 21:679-682.
5. Schoeller D.A., Cella L.K., Sinha M.K., Caro J.F. Entrainment of the diurnal rhythm of plasma leptin to meal timing. JClin Invest 1997, 100:1882-1887.
6. Qin L.Q., Li J., Wang Y., Wang J., Xu J.Y., Kaneko T. The effects of nocturnal life on endocrine circadian patterns in healthy adults. Life Sci 2003, 73:2467-2475.
7. Shea S.A., Hilton M.F., Orlova C., Ayers R.T., Mantzoros C.S. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. JClin Endocrinol Metab 2005, 90:2537-2544.
8. Saad M.F., Riad-Gabriel M.G., Khan A., Sharma A., Michael R., Jinagouda S.D., et al. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity. JClin Endocrinol Metab 1998, 83:453-459.
9. Licinio J., Negrao A.B., Mantzoros C., Kaklamani V., Wong M.L., Bongiorno P.B., et al. Sex differences in circulating human leptin pulse amplitude: clinical implications. JClin Endocrinol Metab 1998, 83:4140-4147.
10. Kok S.W., Meinders A.E., Overeem S., Lammers G.J., Roelfsema F., Frolich M., et al. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. JClin Endocrinol Metab 2002, 87:805-809.
11. Hsuchou H., He Y., Kastin A.J., Tu H., Markadakis E.N., Rogers R.C., et al. Obesity induces functional astrocytic leptin receptors in hypothalamus. Brain 2009, 132:889-902.
12. Pan W., Hsuchou H., He Y., Kastin A.J. The astroglial leptin receptors and obesity. Modern insights into disease - from molecules to man: adipokines 2011, 185-196. Science Publishers, Enfield, NH, USA. V.R. Preedy (Ed.).
13. Pan W., Hsuchou H., Jayaram B., Khan R.S., Huang E.Y.K., Wu X., et al. Leptin action on non-neuronal cells in the CNS: potential clinical implications. Ann N Y Acad Sci 2012, 1264:64-71.
14. Gangwisch J.E., Malaspina D., Boden-Albala B., Heymsfield S.B. Inadequate sleepas a risk factor for obesity: analyses of the NHANES I. Sleep 2005, 28:1289-1296.
15. Peppard P.E., Young T., Barnet J.H., Palta M., Hagen E.W., Hla K.M. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 2013.
16. Taheri S., Lin L., Austin D., Young T., Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004, 1:e62.
17. Mullington J.M., Chan J.L., Van Dongen H.P., Szuba M.P., Samaras J., Price N.J., et al. Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men. JNeuroendocrinol 2003, 15:851-854.
18. Spiegel K., Leproult R., L'hermite-Baleriaux M., Copinschi G., Penev P.D., Van C.E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. JClin Endocrinol Metab 2004, 89:5762-5771.
19. Knutson K.L., Galli G., Zhao X., Mattingly M., Cizza G. No association between leptin levels and sleep duration or quality in obese adults. Obesity (Silver Spring) 2011, 19:2433-2435.
20. Benedict C., Shostak A., Lange T., Brooks S.J., Schioth H.B., Schultes B., et al. Diurnal rhythm of circulating nicotinamide phosphoribosyltransferase (Nampt/visfatin/PBEF): impact of sleep loss and relation to glucose metabolism. JClin Endocrinol Metab 2012, 97:E218-E222.
21. Schmid S.M., Hallschmid M., Jauch-Chara K., Born J., Schultes B. Asingle night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men. JSleep Res 2008, 17:331-334.
22. Schmid S.M., Hallschmid M., Jauch-Chara K., Wilms B., Benedict C., Lehnert H., et al. Short-term sleep loss decreases physical activity under free-living conditions but does not increase food intake under time-deprived laboratory conditions in healthy men. Am J Clin Nutr 2009, 90:1476-1482.
23. Klingenberg L., Chaput J.P., Holmback U., Jennum P., Astrup A., Sjodin A. Sleep restriction is not associated with a positive energy balance in adolescent boys. Am J Clin Nutr 2012, 96:240-248.
24. Charles L.E., Gu J.K., Andrew M.E., Violanti J.M., Fekedulegn D., Burchfiel C.M. Sleep duration and biomarkers of metabolic function among police officers. JOccup Environ Med 2011, 53:831-837.
25. Reynolds A.C., Dorrian J., Liu P.Y., Van Dongen H.P., Wittert G.A., Harmer L.J., et al. Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men. PLoS One 2012, 7:e41218.
26. van Leeuwen W.M., Hublin C., Sallinen M., Harma M., Hirvonen A., Porkka-Heiskanen T. Prolonged sleep restriction affects glucose metabolism in healthy young men. Int J Endocrinol 2010, 2010:108641.
27. Simpson N.S., Banks S., Dinges D.F. Sleep restriction is associated with increased morning plasma leptin concentrations, especially in women. Biol Res Nurs 2010, 12:47-53.
28. Omisade A., Buxton O.M., Rusak B. Impact of acute sleep restriction on cortisol and leptin levels in young women. Physiol Behav 2010, 99:651-656.
29. Nedeltcheva A.V., Kilkus J.M., Imperial J., Kasza K., Schoeller D.A., Penev P.D. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr 2009, 89:126-133.
30. Haynes W.G., Morgan D.A., Walsh S.A., Mark A.L., Sivitz W.I. Receptor-mediated regional sympathetic nerve activation by leptin. JClin Invest 1997, 100:270-278.
31. Scarpace P.J., Matheny M., Pollock B.H., Tumer N. Leptin increases uncoupling protein expression and energy expenditure. Am J Physiol 1997, 273:E226-E230.
32. Carter J.R., Durocher J.J., Larson R.A., DellaValla J.P., Yang H. Sympathetic neural responses to 24-hour sleep deprivation in humans: sex differences. Am J Physiol Heart Circ Physiol 2012, 302:H1991-H1997.
33. Spiegel K., Tasali E., Penev P., Van C.E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850.
34. Martins P.J., Fernandes L., de Oliveira A.C., Tufik S., D'Almeida V. Type of diet modulates the metabolic response to sleep deprivation in rats. Nutr Metab (Lond) 2011, 8:86.
35. Koban M., Swinson K.L. Chronic REM-sleep deprivation of rats elevates metabolic rate and increases UCP1 gene expression in brown adipose tissue. Am J Physiol Endocrinol Metab 2005, 289:E68-E74.
36. Barf R.P., Desprez T., Meerlo P., Scheurink A.J. Increased food intake and changes in metabolic hormones in response to chronic sleep restriction alternated with short periods of sleep allowance. Am J Physiol Regul Integr Comp Physiol 2012, 302:R112-R117.
37. Pan W., Kastin A.J. Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system. Life Sci 2001, 68:2705-2714.
38. Bodosi B., Gardi J., Hajdu I., Szentirmai E., Obal F., Krueger J.M. Rhythms of ghrelin, leptin, and sleep in rats: effects of the normal diurnal cycle, restricted feeding, and sleep deprivation. Am J Physiol Regul Integr Comp Physiol 2004, 287:R1071-R1079.
39. Gonnissen H.K., Hursel R., Rutters F., Martens E.A., Westerterp-Plantenga M.S. Effects of sleep fragmentation on appetite and related hormone concentrations over 24h in healthy men. Br J Nutr 2012, 1-9.
40. Laposky A.D., Shelton J., Bass J., Dugovic C., Perrino N., Turek F.W. Altered sleep regulation in leptin-deficient mice. Am J Physiol Regul Integr Comp Physiol 2006, 290:R894-R903.
41. Laposky A.D., Bradley M.A., Williams D.L., Bass J., Turek F.W. Sleep-wake regulation is altered in leptin-resistant (db/db) genetically obese and diabetic mice. Am J Physiol Regul Integr Comp Physiol 2008, 295:R2059-R2066.
42. Everson C.A., Szabo A. Repeated exposure to severely limited sleep results in distinctive and persistent physiological imbalances in rats. PLoS One 2011, 6:e22987.
43. Shamsuzzaman A.S., Gersh B.J., Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAm Med Assoc 2003, 290:1906-1914.
44. McArdle N., Hillman D., Beilin L., Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007, 175:190-195.
45. Seif F., Patel S.R., Walia H., Rueschman M., Bhatt D.L., Gottlieb D.J., et al. Association between obstructive sleep apnoea severity and endothelial dysfunction in an increased background of cardiovascular burden. JSleep Res 2013, 22:443-451.
46. Tatsumi K., Kasahara Y., Kurosu K., Tanabe N., Takiguchi Y., Kuriyama T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 2005, 127:716-721.
47. Kapsimalis F., Varouchakis G., Manousaki A., Daskas S., Nikita D., Kryger M., et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung 2008, 186:209-217.
48. Patel S.R., Palmer L.J., Larkin E.K., Jenny N.S., White D.P., Redline S. Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep 2004, 27:235-239.
49. Sanchez-de-la-Torre M., Mediano O., Barcelo A., Pierola J., de la Pena M., Esquinas C., et al. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath 2012, 16:649-656.
50. Fredheim J.M., Rollheim J., Omland T., Hofso D., Roislien J., Vegsgaard K., et al. Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study. Cardiovasc Diabetol 2011, 10:84.
51. Barcelo A., Barbe F., Llompart E., de la Pena M., Duran-Cantolla J., Ladaria A., et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 2005, 171:183-187.
52. Jayaram B., Pan W., Wang Y., Hsuchou H., Mace A., Cornelissen-Guillaume G.G., et al. Astrocytic leptin-receptor knockout mice show partial rescue of leptin resistance in diet-induced obesity. JAppl Physiol 2013, 114:734-741.
53. Yee B.J., Cheung J., Phipps P., Banerjee D., Piper A.J., Grunstein R.R. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration 2006, 73:209-212.
54. Harsch I.A., Konturek P.C., Koebnick C., Kuehnlein P.P., Fuchs F.S., Pour S.S., et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003, 22:251-257.
55. Cuhadaroglu C., Utkusavas A., Ozturk L., Salman S., Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 2009, 187:75-81.
56. Trenell M.I., Ward J.A., Yee B.J., Phillips C.L., Kemp G.J., Grunstein R.R., et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 2007, 9:679-687.
57. Nakra N., Bhargava S., Dzuira J., Caprio S., Bazzy-Asaad A. Sleep-disordered breathing in children with metabolic syndrome: the role of leptin and sympathetic nervous system activity and the effect of continuous positive airway pressure. Pediatrics 2008, 122:e634-e642.
58. Zirlik S., Hauck T., Fuchs F.S., Neurath M.F., Konturek P.C., Harsch I.A. Leptin, obestatin and apelin levels in patients with obstructive sleep apnoea syndrome. Med Sci Monit 2011, 17:CR159-CR164.
59. Sanner B.M., Kollhosser P., Buechner N., Zidek W., Tepel M. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004, 23:601-604.
60. Huang R., Huang X.Z., Wang H.G., Li M., Xiao Y. Effects of nasal continuous positive airway pressure on serum leptin concentration and the metabolic parameters in obstructive sleep apnea hypopnea syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2004, 26:168-171.
61. Rubinsztajn R., Kumor M., Byskiniewicz K., Chazan R. The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome. Pneumonol Alergol Pol 2006, 74:63-67.
62. Drummond M., Winck J.C., Guimaraes J.T., Santos A.C., Almeida J., Marques J.A. Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med 2008, 8:21.
63. Garcia J.M., Sharafkhaneh H., Hirshkowitz M., Elkhatib R., Sharafkhaneh A. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res 2011, 12:80.
64. Loube D.I., Loube A.A., Erman M.K. Continuous positive airway pressure treatment results in weight less in obese and overweight patients with obstructive sleep apnea. JAm Diet Assoc 1997, 97:896-897.
65. Chin K., Shimizu K., Nakamura T., Narai N., Masuzaki H., Ogawa Y., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999, 100:706-712.
66. Redenius R., Murphy C., O'Neill E., Al-Hamwi M., Zallek S.N. Does CPAP lead to change in BMI?. JClin Sleep Med 2008, 4:205-209.
67. Sinton C.M., Fitch T.E., Gershenfeld H.K. The effects of leptin on REM sleep and slow wave delta in rats are reversed by food deprivation. JSleep Res 1999, 8:197-203.
68. Jenkins J.B., Omori T., Guan Z., Vgontzas A.N., Bixler E.O., Fang J. Sleep is increased in mice with obesity induced by high-fat food. Physiol Behav 2006, 87:255-262.
69. Danguir J. Sleep patterns in the genetically obese Zucker rat: effect of acarbose treatment. Am J Physiol 1989, 256:R281-R283.
70. Megirian D., Dmochowski J., Farkas G.A. Mechanism controlling sleep organization of the obese Zucker rats. JAppl Physiol 1998, 84:253-256.
71. Pan W., Hsuchou H., He Y., Sakharkar A., Cain C., Yu C., et al. Astrocyte leptin receptor (ObR) and leptin transport in adult-onset obese mice. Endocrinology 2008, 149:2798-2806.
72. Wu X., Mishra P.K., Hsuchou H., Kastin A.J., Pan W. Upregulation of astrocytic leptin receptor in mice with experimental autoimmune encephalomyelitis. JMol Neurosci 2013, 49:446-456.
73. vy mice. JMol Neurosci 2011, 43:478-484.
74. Dash M.B., Douglas C.L., Vyazovskiy V.V., Cirelli C., Tononi G. Long-term homeostasis of extracellular glutamate in the rat cerebral cortex across sleep and waking states. JNeurosci 2009, 29:620-629.
75. Halassa M.M., Florian C., Fellin T., Munoz J.R., Lee S.Y., Abel T., et al. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009, 61:213-219.
76. Dworak M., McCarley R.W., Kim T., Kalinchuk A.V., Basheer R. Sleep andbrain energy levels: ATP changes during sleep. JNeurosci 2010, 30:9007-9016.
77. Alberti A., Sarchielli P., Gallinella E., Floridi A., Floridi A., Mazzotta G., et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. JSleep Res 2003, 12:305-311.
78. Steiropoulos P., Kotsianidis I., Nena E., Tsara V., Gounari E., Hatzizisi O., et al. Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep 2009, 32:537-543.
79. Basoglu O.K., Sarac F., Sarac S., Uluer H., Yilmaz C. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med 2011, 6:120-125.
80. Ulukavak C.T., Kokturk O., Bukan N., Bilgihan A. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration 2005, 72:395-401.
81. Ozturk L., Unal M., Tamer L., Celikoglu F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 2003, 129:538-540.
82. Hargens T.A., Guill S.G., Kaleth A.S., Nickols-Richardson S.M., Miller L.E., Zedalis D., et al. Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep Breath 2013, 17:403-409.
83. Papaioannou I., Patterson M., Twigg G.L., Vazir A., Ghatei M., Morrell M.J., et al. Lack of association between impaired glucose tolerance and appetite regulating hormones in patients with obstructive sleep apnea. JClin Sleep Med 2011, 7:486-492.
84. Ursavas A., Ilcol Y.O., Nalci N., Karadag M., Ege E. Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: role of obesity. Ann Thorac Med 2010, 5:161-165.
85. Sharma S.K., Kumpawat S., Goel A., Banga A., Ramakrishnan L., Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007, 8:12-17.